Combating Alzheimer's Through Sleep and Exercise
Not Applicable
Recruiting
- Conditions
- DementiaAlzheimer Disease
- Interventions
- Device: DREEM 2 HeadbandOther: Exercise Routine
- Registration Number
- NCT04855630
- Lead Sponsor
- University of Miami
- Brief Summary
The purpose of this research is to see how sleep and exercise affects dementia risk over time.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Able to perform mild exercise
- Able to wear DREEM 2 Headband
- Able to wear a Fitbit wrist watch
- Able to perform the Everlywell biomarker procedure
- Able to Understand and Speak English
- Able to operate a digital device like mobile phone, iPad, or computer
- Self-reported history of problems with cognitive impairment: memory, concentration, and processing information
- Only participants cognitively able and willing to provide consent will be included.
Exclusion Criteria
- Prohibited from or unable to perform mild exercise
- Unable to wear wrist watch or headband devices, or unable to supply pinprick blood sample for any reason
- Unable to speak or understand English
- Unable to use mobile device/smartphone technology
- Unable or unwilling to consent for any reason.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Sleep Only Group DREEM 2 Headband Participants in this group will wear the DREEM 2 headband for 12 weeks. Exercise Only Group Exercise Routine Participants in this group will workout twice a week for 12 weeks. Exercise and Sleep Group Exercise Routine Participants in this group will take part in a guided exercise program in additional to wearing the DREEM 2 headband for 12 weeks. Exercise and Sleep Group DREEM 2 Headband Participants in this group will take part in a guided exercise program in additional to wearing the DREEM 2 headband for 12 weeks.
- Primary Outcome Measures
Name Time Method Creatinine Levels Up to Week 12 Measured from Urine Sample
Triglycerides Levels Up to Week 12 Measured from blood sample
High-Density Lipoprotein (HDL) Levels Up to Week 12 Measured from blood sample
Blood Pressure Up to Week 12 Measured from Fitbit
Cortisone Levels Up to Week 12 Measured from Urine Sample
HbA1c Levels Up to Week 12 Measured from blood sample
Heart Rate Up to Week 12 Measured from Fitbit
Total Sleep Duration Up to Week 12 Measured from DREEM 2
Slow Wave Sleep Duration Up to Week 12 Measured from DREEM 2
Total Cholesterol Levels Up to Week 12 Measured from blood sample
Low-Density Lipoprotein (LDL) Levels Up to Week 12 Measured from blood sample
High-sensitivity C-reactive protein (hs-CRP) Levels Up to Week 12 Measured from blood sample
Cortisol Levels Up to Week 12 Measured from Urine Sample
Melatonin Levels Up to Week 12 Measured from Urine Sample
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Miami Hospitals
🇺🇸Miami, Florida, United States